Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients

Journal of the Neurological Sciences

Volumn 272, Issue 1-2, 2008, Pages 115-122

  Bandaru, V C S S ^a   Laxmi, V ^a   Neeraja, M ^a   Alladi, S ^a   Meena, A K ^a   Borgohain, R ^a   Keerthi, A S ^a   Kaul, S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

C. pneumoniae; IgA antibody; IgG antibody; Ischemic stroke; Microimmunofluorescence; Stroke subtypes

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHILD; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SAMPLE; SEX; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CONFIDENCE INTERVALS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; STROKE;

EID: 48349098837     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.05.008     Document Type: Article

References (71)

1. Rutherford J.D. Chlamydia pneumoniae and atherosclerosis. Curr Atheroscler Rep 2 (2000) 218-225
2. Aldous M.B., Wang S.P., Foy H.M., and Grayston J.T. Chlamydia pneumoniae, strain TAWAR, infection in Seattle children and their families 1965-1979. In: Bowie W.R., Caldwell H.D., Jones R.P., et al. (Eds). Chlamydia infections (1999), Cambridge University Press, Cambridge, UK 437-440
3. Brassard P., Bourgault C., Brophy J., and Susissa S. Antibiotics in Primary Prevention of Stroke in the Elderly. Stroke 34 (2003) e163-e167
4. Ericson K., Saldeen T.G.P., Lindquistv O., Pahlson C., and Mehta J.L. Relationship Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation 101 (2000) 2568-2571
5. Grau A.J., Buggle F., Ziegler C., Schwarz W., Meuser J., Tasman A.J., et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 28 (1997) 1724-1729
6. Thorvaldsen P., Asplund K., Kuulasmaa K., Rajakangas A.M., and Schorll M. Stroke incidence, case fatality and mortality on WHO MONOCA project. Monitoring Trends and Determinates in Cardiovascular Disease vol. 26 (1995), World Health Organization 361-370
7. Sacco R.L., Gan R., Boden-Albala B., Lin I.F., Kargman D.E., Hauser W.A., et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 29 (1998) 380-387
8. Gentry E.M., Kalsbeek W.D., Hegelin G.C., Jones J.T., Gaines K.L., Forman M.R., et al. The Behavioral Risk factor Surveys, II: design, methods and estimates form combined state data. Am J Prev Med 1 (1985) 9-14
9. Sacco R.L., Roberts J.K., Boden-Albala B., Gu Q., Lin I.F., Kargaman D.E., et al. Race-ethnicity and determinants of carotid atherosclerosis in a multi-ethnic population: the North Manhattan Stroke Study. Stroke 28 (1997) 929-935
10. Britov A.N., and Bystrova M.M. New guidelines of Joint National Committee (USA) on prevention, Diagnosis and Management of Hypertension. From JNC VI to JNC VII. Kardiologiia 43 (2003) 93-97
11. Radhakrishnamurthy B. Diabetes Mellitus: In Heart Disease (2003), Quill publication, Columbus, GA 31-37
12. Radhakrishnamurthy B. Blood Lipid: In Heart Disease (2003), Quill publication, Columbus, GA 18-27
13. Ueland P.M., Refsum H., Stabler S.P., Malinow R., Andersson A., and Allen R.H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39 (1993) 1764-1779
14. Nehler M.R., Taylor Jr. L.M., and Porter J.M. Homocysteine as a risk factor for atherosclerosis: a review. Cardivasc Pathol 6 (1997) 1-9
15. Lussier-Cacan S., Xhignesse M., Piolot A., Davignon J., and Genest Jr. J. Plasma total homocysteine in healthy subject: sex-specific relation with biological traits. Am J Clin Nutr 64 (1996) 587-593
16. Clarke R., Woodhouse P., Ulvik A., Frost C., Sherliker P., Refsum H., et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 44 (1998) 102-107
17. Glader C.A., Boman J., Saikku P., Stenlund H., Weinehall L., Hallmanns G., et al. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae specific IgG antibodies. Eur Heart J 21 (2000) 639-646
18. Saponsik G., Caplan L.R., Gonzalez L.A., Baird A., Dashe J., Luraschi A., et al. Differences in stroke subtypes among natives and Caucasians in Boston and Buenos Aires. Stroke 31 (2000) 2385-2389
19. Radhakrishnamurthy B. Obesity: In Heart Disease (2003), Quill publication, Columbus, GA 38-43
20. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gardon D.L., et al. Classification of subtypes of acute ischemic stroke. Definition for use in a multicenter clinical trail. Stroke 24 (1993) 35-41
21. Elkind M.S.V., Lin I.F., Grayston J.T., and Sacco R.L. Chlamydia pneumoniae and risk of first ischemic stroke: the Northern Manhattan Stroke Study. Stroke 31 (2000) 1521-1525
22. Cook P.J., Honeybourne D., Lip G.Y.H., Beevers D.G., Wise R., and Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. Stroke 29 (1998) 404-410
23. Fagerberg B., Gnarpe J., Gnarpe H., Agewall S., and Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 30 (1999) 299-305
24. Gan R., Sacco R.L., Kargman D.E., Roberts J.K., Boden-Albala B., and Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology 48 (1997) 1204-1211
25. Kawashima N., and Kawada J. Chlamydia pneumoniae antibody titers in patients with acute ischemic stroke. Rinsho Shinkeigaku 40 (2000) 1063-1068
26. Kawamoto R., Kajiwara T., Oka Y., and Takagi T. An association between and antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med 42 (2003) 571-575
27. Voorend M., Faber C.G., van der Ven A.J.A.M., Kessels F., Bruggeman C.A., and Lodder J. Chlamydia pneumoniae is likely risk factor far ischemic stroke in young patients. J Stroke Cerebrovas Dis 13 (2004) 85-91
28. Melnick S.L., Shakar E., Folsom A.R., Grayston J.T., Sonlie P.D., Wang S.P., et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95 (1993) 499-504
29. Schmidt C., Hulthe J., Wikstrand J., Gnarpe H., Gnarpe J., Agewall S., et al. Chlamydia pneumoniae seropositivity is associated with carotid artery intima media thickness. Stroke 31 (2000) 1526-1531
30. Gibbs R.G.J., Carey N., and Davies A.H. Chlamydia pneumoniae and vascular disease. Br J Surg 85 (1998) 1191-1197
31. Ward M.E. The immunobiology and immunopathology of Chlamydia pneumoniae infection. APMIS 103 (1995) 769-796
32. Krull M., Klucken A.C., Wuppermann F.N., Fuhrmann O., Magen C., Seybold J., et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J immunol 162 (1999) 4834-4841
33. Yamashita K., Ouch K., Shirai M., Gondo T., Nzkazawa T., and Ito H. Distribution of Chlamydia pneumoniae infection in the atherosclerotic artery. Stroke 29 (1989) 777-778
34. Kalayoglu M.V., and Byrne G.I. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 177 (1998) 725-729
35. Ezzahiri R., Nelssen-Vrancken H., Kurvers H., Sassen F.R., Vliegen I., Grauls G.E., et al. Chlamydiphila pneumoniae (Chlamydia pneumoniae) accelerates formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc Res 56 (2002) 269-276
36. Heuschmann P.U., Neureiter D., Gesslein M., Craiovan B., Maass M., Faller G., et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes. Stroke 32 (2001) 2253-2258
37. Fisher C.M. Capsular infarcts: the underlying vascular lesions. Arch Neurolol 36 (1979) 65-73
38. Virok D., Kis Z., Karai L., Intzedy L., Burian K., Szabo A., et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 32 (2001) 1973-1978
39. Vink A., Poppen M., Schoneveld A.H., Rohall P.J.M., de Kleijn D.P.V., Borst C., et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis with individual. Circulation 103 (2001) 1613-1617
40. Thom D.H., Grayston J.T., Siscovitch D.S., Wang S.P., Weiss N.S., and Dailing J.R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268 (1992) 68-72
41. Anzini A., Cassone A., Rasura M., Ciervo A., Beccia M., Di Lisi F., et al. Chlamydia pneumoniae infection in young stroke patients: a case control study. Eur J Neurol 11 (2004) 321-327
42. Wimmer K.L.J., Sandmann-Strupp R., Saikku P., and Haberl R.L. Association of Chlamydial infection with cerebrovascular Disease. Stroke 27 (1996) 2207-2210
43. Ngesh J., Gupta S., Goodbourn C., Panayitou B., and Mc Elligott G. Chlamydia pneumoniae in elderly patients with stroke(C-PEPS): a case control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 15 (2003) 11-16
44. Njamnshi A.K., Blackett K.N., Mbagbow J.N., Gumedze F., Gupta S., and Wiysonge C.S. Chronic Chlamydia pneumoniae infection and stroke in Cameroon. Stroke 37 (2006) 796-799
45. Zhu J., Shearer G.M., Norman J.E., Pinto L.A., Marincla F.M., Prasad A., et al. Host responses to cytomegalovirus infection as determinant of susceptibility to coronary artery disease: sex-based differences inflammation and type of immune response. Circulation 102 (2000) 2491-2496
46. Elkind M.S.V., Sciacca R., Boden-Albala B., Homma S., and Di Tullio M.R. Leukocyte count is associated with endothelial reactivity. Atherosclerosis 181 (2005) 329-338
47. Cook P.J., Honeybourne D., Lip G.Y.H., Beevers D.G., and Wise R. Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation 92 (1995) 3148-3149
48. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 14 (1993) 57-61 (SupplK)
49. Kuo L.A., Campbell C.C., and Grayston J.T. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?. Mol Med Today 4 (1998) 426-430
50. Grayston J.T. Infections caused by Chlamydia pneumoniae TWAR. Clin Infect Dis 15 (1992) 757-761
51. Ekmann M.R., Leinonen M., Syrjala H., Linnanmaki E., Kujala P., and Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 27 (1993) 756-760
52. Dowell S.F., Boman J., Carlone G.M., Fields B.S., Guarner M.R., Hammerschlag J., et al. Standardizing Chlamydia pneumoniae assays: recommendations form the Center for Disease Control and Prevention (USA) and the Laboratory Center for Disease Control (Canada). Clin Infect Dis 33 (2001) 492-503
53. Essig A., Simnacher U., Susa M., and Marre R. Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. Clin Diagn Lab Immunol 6 (1999) 819-825
54. Larsen M.M., Moern B., Fuller A., Andersen P.L., and Ostergaard L.J. Chlamydia pneumoniae and cardiovascular disease. MJA 177 (2002) 558-562
55. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., et al. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infection. Lancet 2 (1988) 983-985
56. Saikku P., Leinonen M., Tenkanen L., Linnanmaki E., Ekman M.R., Manninen V., et al. Chronic Chlamydia pneumoniae infection a risk factor for coronary heart disease in the Hesinki Heart Study. Ann Intern Med 116 (1992) 273-278
57. Madre J.G., Garcia J.L., Gonzalez R.C., Montero J.M., Paniagua E.B., Escribano J.R., et al. Association between seropositivity to Chlamydia pneumoniae and acute ischemic stroke. Eur J Neurol 9 (2002) 303-306
58. Hahn D.L., Anttil T., and Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 117 (1996) 513-517
59. Von Hertzen L., Alakarppa H., Koskinen R., Liippo K., Surcel H.M., Leinone M., et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 118 (1997) 155-164
60. Chaim W., Sarov B., Sarov I., Piura V., Cohen A., and Insler V. Serum IgG and IgA antibodies to Chlamydia in ectopic pregnancies. Contraception 40 (1989) 59-71
61. Hoiby N., and Doring G. Immunoglobulin responses and immune complex formation in chronic lung disease. Clin Microbiol Newsl 9 (1988) 133-136
62. Brett M.M., Ghoneim A.T., and Littlewood J.M. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child 65 (1990) 259-263
63. Gransfors K. Measurement of immunoglobulin M(IgM), IgG and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J Clin Microbiol 9 (1979) 336-341
64. Glader C.A., Stegmayr B., Boman J., Stenlund H., Weinehall L., and Dahlen G.H. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarction. Results from a nested case-control study in northern Sweden. Stroke 30 (1999) 2013-2018
65. Altman R., Rouvier J., Scazziota A., Absi R.S., and Gonzalez C. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease. Clin Cardiol 22 (1999) 85-90
66. Maass M., Gieffers J., Krause E., Engel P.M., Bartels C., and Solbach W. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol (Berl) 187 (1998) 103-106
67. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., and Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96 (1997) 404-407
68. Gurfinkel E., Bozovich G., Beck E., Testa E., Livellara B., and Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The Final report of the ROXIS study. Eur Heart J 20 (1999) 121-127
69. Anderson J.B., Muhlestein J.L., Czrlquist J., Allen A., Trehan S., Nielson C., et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The azithromycin in coronary artery disease: Elimination of myocardial infection with Chlamydia (ACADEMIC) study. Circulation 99 (1999) 1540-1547
70. Dunne M.W. Rationale and design of a secondary prevention trail of antibiotic use in patients after myocardial infarction: The WIZARD(weekly intervention with zithromax[azithromycin] for atherosclerosis and its related disorders) trial. J Infect Dis 181 (2000) S572-S578 (Suppl)
71. Jackson L.A. Description and status of the azithromycin and coronary events study(AEES). J Infect Dis 181 (2000) S579-S581 (Suppl)